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Abstract
Surgical management of inflammatory bowel disease (IBD) still presents a challenge for surgeons. Pre-operative optimization 
(PO) is a bundle of measures to bring the patient in optimal condition to surgery and to reduce the risk of unfavorable post-operative 
outcome. PO in patients with IBD is often suboptimal, and the evidence supporting it is scanty calling for more attention. This mini-
review shows the most important pre-operative measures that can optimize the patients with IBD. These measures are optimization 
of medical treatment, nutritional support, treatment of pre-operative sepsis, thrombosis prophylaxis, bowel preparation, pre-oper-
ative antibiotics treatment, cessation of smoking and psychological support. This bundle is to be provided by a multi-disciplinary 
team, which includes gastroenterologist, surgeon, IBD nurse, dietitian, radiologist and other health care providers if needed.
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Introduction
Surgical management of inflammatory bowel disease (IBD) still presents a challenge for surgeons. The timing of operation depends 
on disease severity, disease presentation, medical treatment, patients’ perspectives, and pre-operative optimization (PO) [1]. PO is used 
to bring the patient in optimal condition to surgery and to reduce the risk of unfavorable post-operative outcome [2]. PO in patients with 
IBD is often suboptimal, and the evidence supporting it is scanty calling for more attention [3]. Keywords: Surgical Intervention; Inflam-
matory Bowel Disease (IBD) Few studies attempted to provide evidence-based clear recommendations for PO of patients with IBD. There 
is a need for well-designed prospective studies to explore the effect of PO on post-operative outcome and length of stay in hospital. PO 
might also be a factor in reduction of health care costs. The PO typical regime can be summarised as follows
Cardinal factors in pre-operative optimization of patients with IBD
Pharmacological considerations
Pre-operative medications
The impact of corticosteroids on surgical outcome was investigated in a meta-analysis of observational studies which showed an in-
creased risk of all post-operative complications especially infectious complications. Gradual withdraw of steroids should be attempted, so 
that the patient is steroid free for 1 week prior to surgery Oxford evidence level IIb.
Two reviews investigated the Immuno-modulators’ effect on post-operative complications and found no increase in the risk of post-
operative complications [5,6]. No indication to withdraw immunomodulators prior to surgical intervention Oxford evidence level III.
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There are 106 studies about the impact of anti-tumor necrosis factor-α agents (anti-TNF-α) on post-operative outcome with divergent 
conclusions [7]. It seems that the impact of anti-TNF-α is affected by an interplay of many factors; the most important of these factors are 
disease severity, nutritional status, concomitant steroid treatment, drug concentration in blood and the presence of anti-drug antibodies. 
Withdrawal of anti-TNF-α is not supported by current evidence Oxford evidence level III. 
Steroid stress dose
This, well entrenched practice, is based on two case reports from 1960s. No evidence to support administration of supra-physiological 
dose of steroid at the induction of anaesthesia in patients on regular steroid treatment [8]. The patient need only his/her regular steroid 
dose at the day of operation Oxford evidence level Ib.
Nutritional support
An abundance of studies described the effect of nutritional therapy on remission of IBD, but the evidence of nutrition as a PO factor is 
less studied [9,10]. There are two rationales for nutritional support prior to surgery. First, treatment of malnutrition is advised since it has 
been well established that malnutrition is an important risk factor for post-operative complications and mortality [11]. The second is to 
modify the underlying inflammatory process and reduce disease activity prior to surgery. Reviews conclude that nutritional support for 
malnourished CD patients (at least 10 - 14 days prior to surgery) is important and that parenteral nutrition should only be used for those 
who cannot tolerate enteral nutrition [12-14]. All IBD patients should be screened for malnutrition pre-operatively. There is no standard-
ized test for malnutrition. The European Society for Parenteral and Enteral Nutrition recommend NRS-2002, which primarily considers 
four clinical parameters: BMI, weight loss, reduced dietary intake, and severe illness [15]. Malnutrition must be corrected prior to surgical 
intervention. Anaemia can be treated with ferric injections Oxford evidence level III. 
Thrombosis prophylaxis
It is well established that patients with IBD carry a high risk of venous thromboembolism (VTE) [16-18]. The mechanism of hyperco-
agulability in IBD is multifactorial and consists of acquired factors such as inflammation, vitamin deficiencies, surgery, steroid therapy, 
and fluid depletion along with a pro-thrombotic condition and hypercoagulability state [17].
All current guidelines recommend the use of anticoagulants to prevent VTE in all hospitalized IBD patients. However, data is regard-
ing thrombosis prophylaxis in patients with IBD undergoing surgery is scanty. A recent systematic review [4] identified six retrospective 
studies investigating the incidence of post-operative VTE in patients with IBD [19].
Patients with IBD, who are not at high risk of bleeding, should receive pre- and post-operative anticoagulants during their hospital stay 
in order to prevent VTE.
The evidence supporting 4 - week thrombosis prophylaxis after discharge is scanty Oxford evidence level III.
Treatment of pre-operative sepsis
The presence of intra-abdominal abscess at the time of surgery is risk factor for post-operative septic complications [11,20]. Treat-
ments include antibiotics (Abs), percutaneous abscess drainage (PAD) and surgical drainage (SD). There is a significant increase in the use 
of PAD and decrease in SD. Ultra-sound or CT-guided drainage of abscess is recommended prior to surgery, preferably with antibacterial 
coverage. There is no clear recommendation in the literature about how many days/weeks surgical intervention should be performed 
after abscess drainage Oxford evidence level III.
Prophylactic antibiotics
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Administration of AB prophylaxis prior to surgery is nowadays embedded into surgical practice with significant effect on the rate of 
surgical site infections (SSIs) [20]. Timing of administration is debated and evidence is lacking in IBD [20]. The effect of AB therapy for a 
longer period other than the routine perioperative administration is still unclear [21-23]. Zerbib., et al. described 78 patients with CD who 
underwent PO including over 2 weeks of intravenous AB, withdrawal from steroids and immunosuppressive therapy, abscess drainage, 
and nutritional support [24]. The study showed low rates of morbidity (18%) and no mortality in treated patients. Oral AB 24 hour prior 
to open surgery might be considered complementary to IV perioperative AB. However, this short interval can cause microbes resistant. 
Longer peri-operative AB treatment is not supported by evidence Oxford evidence level III.
Bowel preparation
Although bowel preparation (MBP) prior to surgery is discussed extensively in the literature, there is little data about this pre-opera-
tive measure specifically in patients with IBD. Literature on the subject refers to IBD as part of a larger group of diseases treated surgically. 
Two large studies compared patients that received mechanical bowel preparation with or without oral ABs with patients who did not 
receive bowel preparation [23,25], showed that MBP with oral ABs prior to surgery could reduce the rate of surgical site infections, length 
of stay at hospital, and readmission rate. A recent study by Iesalnieks., et al. concluded that pre-operative MPB should be strongly consi-
dered before colorectal surgery in patients with CD, especially in patients undergoing ileocolic resections for penetrating disease [26]. 
Combined ABs and mechanical bowel preparation prior to IBD surgery is recommended Oxford evidence level III.
Smoking cessation
Smoking has a significant effect on the course of IBD. There is a fair amount of data about the effect of smoking and smoking cessation 
on the clinical course of IBD. However, only a few studies addressed the effect of smoking cessation on the surgical outcomes [27-29]. All 
patients with IBD should be advised to stop smoking prior to elective surgery Oxford evidence level III.
Other considerations
In addition to the above-mentioned interventions, treatment of co-morbidities, psychological support, multi-disciplinary approach to 
manage patients with IBD in high volume hospital might also have an impact on post-operative outcome and must always be addressed. 
Pre-operative optimization may reduce the unfavourable post-operative outcome [30].
A bundle of measurements to optimize patients with IBD is mandatory to improve post-operative outcome. Among the most important 
elements in this bundle are withdrawal of steroids, nutritional support [31], prophylaxis against thromboembolism, prophylactic antibi-
otic, combined mechanical and oral antibiotic for bowel preparation. 
Conclusion
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